Indication
Crohn
1 clinical trial
1 product
Clinical trial
Phase I Study of Dose Escalation of Human Allogenic Adipose-derived Stem Cells (ALLO-ASC) to Evaluate Safety and Efficacy in Patients With Crohn's FistulaStatus: Completed, Estimated PCD: 2012-10-11